Oculis Holding AG (NASDAQ: OCSAW)
$1.84
-0.0700 ( -3.66% ) 3.7K
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
Market Data
Open
$1.84
Previous close
$1.91
Volume
3.7K
Market cap
$109.05M
Day range
$1.85 - $2.16
52 week range
$0.76 - $2.98
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 6 | Nov 15, 2023 |
| 6-k | Quarterly Reports | 6 | Aug 29, 2023 |
| 6-k | Quarterly Reports | 37 | Aug 08, 2023 |
| 6-k | Quarterly Reports | 78 | Jul 12, 2023 |
| 6-k | Quarterly Reports | 1 | Jul 06, 2023 |